Background In 2012, a European initiative called S ingle H ub and A ccess point for pediatric
R heumatology in E urope (SHARE) was launched to optimise and disseminate diagnostic …

The idiopathic inflammatory myopathies, including adult and juvenile dermatomyositis (DM),
polymyositis (PM), and inclusion body myositis (IBM), are rare systemic autoimmune …

Background Most data for treatment of dermatomyositis and juvenile dermatomyositis are
from anecdotal, non-randomised case series. We aimed to compare, in a randomised trial …

Objective To identify the clinical and laboratory predictors of clinical improvement in a cohort
of myositis patients treated with rituximab. Methods We analyzed data for 195 patients with …

Autoimmune diseases affect up to 10% of the world's population and, as a whole, they are
far more common in females, although differences exist according to the single disease and …

The aim of this review was to summarize recent advances in the understanding of the
clinical and autoantibody phenotypes, their associated outcomes and the pathogenesis of …

The juvenile idiopathic inflammatory myopathies (JIIM) are systemic autoimmune diseases
characterized by skeletal muscle weakness, characteristic rashes, and other systemic …

Objective To propose a common nomenclature to refer to individuals who fulfill the American
College of Rheumatology classification criteria for systemic lupus erythematosus (SLE) …

Objective. Rapidly progressive interstitial lung disease (RP-ILD) is a rare but potentially fatal
complication of JDM. The aim of this study was to establish markers for the prediction and …

The childhood-onset or juvenile idiopathic inflammatory myopathies (JIIMs) are a
heterogenous group of rare and serious autoimmune diseases of children and young …